| Oligometastatic Prostate Carcinoma studied in …STUDIED_INderived11 of 11show fewer |
|---|
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205316Phase 3 · active not recruiting SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053152Phase 2 · active not recruiting Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04190446Phase 2 · active not recruiting A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496959Phase 2 · active not recruiting 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389786NA · recruiting Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06229366Phase 1 · active not recruiting [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674863NA · recruiting Addressing Health Literacy With a Tailored Survivorship Care Plan · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06273345recruiting OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05707468NA · not yet recruiting Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585932Phase 2 · withdrawn Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study · condition mapped ONTOLOGY_EXACT · 11 trials mapped (10 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |